Carbenicillin and gentamicin: pharmacologic studies in patients with cystic fibrosis and pseudomonas pulmonary infections.
D000293:Adolescent; D002228:Carbenicillin / Q000008:administration & dosage / Q000032:analysis / Q000097:blood / Q000494:pharmacology; D002648:Child; D002675:Child, Preschool; D003550:Cystic Fibrosis / Q000150:complications*; D004357:Drug Synergism; D005260:Female; D005839:Gentamicins / Q000008:administration & dosage / Q000032:analysis / Q000097:blood / Q000494:pharmacology*; D006801:Humans; D007275:Injections, Intravenous; D008171:Lung Diseases / Q000150:complications* / Q000188:drug therapy / Q000209:etiology; D008297:Male; D010406:Penicillins / Q000494:pharmacology*; D011552:Pseudomonas Infections / Q000150:complications* / Q000188:drug therapy; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000302:isolation & purification; D013183:Sputum / Q000032:analysis / Q000382:microbiology; D013997:Time Factors
D005839:Gentamicins; D010406:Penicillins; D002228:Carbenicillin